CAH

MKT CAP:$47B

Cardinal Health, Inc.

Market Cap

$47B

Healthcare·Medical - Distribution·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$200.27-$5.45 (-2.65%)

Apr 24, 2026

Company Details

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambula...

CEO

Jason Hollar

IPO Date

Aug 4, 1983

Website

www.cardinalhealth.com

Key Metrics TTM

Revenue

$227.9B

+9.2% YoY

Net Income

$1.8B

EPS (Diluted)

$7.42

Free Cash Flow

$1.1B

Revenue / Share

$961.43

Gross Margin

3.6%

Operating Margin

1.1%

Net Margin

0.8%

FCF Margin

0.5%

P/S

0.2x

P/E

26.3x

Earnings Reports

Q3 2026

Apr 30, 2026

PENDING

Q2 2026

Feb 5, 2026

$65.4B+18.4%EPS $1.97

Q3 2025

May 1, 2025

$54.9B+0.0%EPS $2.10

Q2 2025

Jan 30, 2025

$55.3B-3.8%EPS $1.65

Q1 2025

Nov 1, 2024

$52.3BEPS $1.70

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 20	$37.3B	$1.7B	-$5.3B
Q2 20	$39.7B	$1.7B	$334M
Q3 20	$39.2B	$1.9B	$562M
Q4 20	$36.7B	$1.6B	$270M
Q1 21	$39.1B	$1.7B	-$624M
Q2 21	$41.5B	$1.8B	$461M
Q1 22	$44.0B	$1.6B	$415M
Q2 22	$45.5B	$1.6B	-$950M
Q3 22	$44.8B	$1.7B	-$97M
Q2 23	$51.5B	$1.7B	-$119M
Q2 24	$57.4B	$1.8B	$505M
Q3 24	$54.9B	$1.9B	$369M
Q1 25	$52.3B	$1.9B	$568M
Q2 25	$55.3B	$1.9B	$549M
Q3 25	$54.9B	$2.1B	$730M
Q2 26	$65.4B	$2.2B	$707M

Valuation

Quarter	P/S	P/E
Q1 20	0.1x	—
Q2 20	0.1x	—
Q3 20	0.1x	—
Q4 20	0.1x	—
Q1 21	0.1x	14.3x
Q2 21	0.1x	11.4x
Q1 22	0.1x	11.3x
Q2 22	0.1x	20.5x
Q3 22	0.1x	—
Q2 23	0.1x	—
Q2 24	0.1x	—
Q3 24	0.1x	—
Q1 25	0.1x	29.2x
Q2 25	0.1x	19.7x
Q3 25	0.2x	20.8x
Q2 26	0.2x	27.5x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 20	-$653M	-$725M
Q2 20	$697M	$620M
Q3 20	$1.7B	$1.6B
Q4 20	$240M	$104M
Q1 21	$270M	$192M
Q2 21	$1.2B	$1.1B
Q1 22	-$646M	-$713M
Q2 22	$1.2B	$1.1B
Q3 22	-$419M	-$501M
Q2 23	$597M	$512M
Q2 24	$1.2B	$1.1B
Q3 24	-$27M	-$139M
Q1 25	-$1.6B	-$1.7B
Q2 25	-$400M	-$499M
Q3 25	$2.9B	$2.8B
Q2 26	$686M	$555M

Capital Expenditures

Quarter	CapEx
Q1 20	$72M
Q2 20	$77M
Q3 20	$90M
Q4 20	$136M
Q1 21	$78M
Q2 21	$96M
Q1 22	$67M
Q2 22	$74M
Q3 22	$82M
Q2 23	$85M
Q2 24	$114M
Q3 24	$112M
Q1 25	$90M
Q2 25	$99M
Q3 25	$126M
Q2 26	$131M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 20	+5.6%	+17.0%
Q2 20	+12.8%	+14.5%
Q3 20	+3.8%	+3.6%
Q4 20	+4.1%	+4.7%
Q1 21	+4.6%	-6.8%
Q2 21	+4.5%	+4.3%
Q1 22	+12.3%	+12.8%
Q2 22	+23.9%	+27.4%
Q3 22	+14.8%	+13.2%
Q2 23	+23.9%	+25.6%
Q2 24	+30.6%	+30.7%
Q3 24	+20.7%	+17.4%
Q1 25	+16.6%	+15.1%
Q2 25	+7.4%	+6.1%
Q3 25	-4.5%	-4.9%
Q2 26	+19.3%	+18.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 20	$20M	0.1%
Q2 20	$21M	0.1%
Q3 20	$27M	0.1%
Q4 20	$22M	0.1%
Q1 21	$28M	0.1%
Q2 21	$23M	0.1%
Q1 22	$24M	0.1%
Q2 22	$18M	0.0%
Q3 22	$23M	0.1%
Q2 23	$25M	0.0%
Q2 24	$28M	0.0%
Q3 24	$31M	0.1%
Q1 25	$30M	0.1%
Q2 25	$30M	0.1%
Q3 25	$31M	0.1%
Q2 26	$87M	0.1%

OpEx Breakdown

Quarter	G&A	S&M	SG&A
Q1 20	—	$1.1B	—
Q2 20	$1.2B	—	—
Q3 20	—	$1.2B	—
Q4 20	$1.1B	—	—
Q1 21	—	$1.1B	—
Q2 21	—	$1.1B	—
Q1 22	—	$1.1B	—
Q2 22	—	$1.2B	—
Q3 22	—	$1.1B	—
Q2 23	—	$1.2B	—
Q2 24	—	—	$1.3B
Q3 24	—	—	$1.3B
Q1 25	—	$1.3B	—
Q2 25	—	$1.3B	—
Q3 25	—	$1.3B	—
Q2 26	—	$1.5B	—

Revenue Segments

Quarter	Cardinal Health At Home Solutions	Medical Member	Nuclear Precision Health Services	Pharmaceutical Member	Gmpd	Other Operating Segment
Q1 20	$471M	$3.4B	$216M	$33.2B	—	—
Q2 20	$525M	$3.5B	$213M	$35.5B	—	—
Q3 20	$512M	$3.5B	$213M	$34.9B	—	—
Q4 20	$507M	$2.9B	$160M	$33.1B	—	—
Q1 21	$519M	$3.4B	$196M	$34.9B	—	—
Q2 21	$581M	$3.7B	$196M	$37.0B	—	—
Q1 22	$582M	$3.6B	$208M	$39.6B	—	—
Q2 22	$639M	$3.4B	$211M	$41.2B	—	—
Q3 22	$601M	$3.3B	$234M	$40.7B	—	—
Q2 23	$698M	$3.1B	$282M	$47.4B	—	—
Q2 24	$761M	$3.2B	$330M	$53.2B	—	—
Q3 24	—	—	—	$50.7B	$3.1B	$1.2B
Q1 25	—	—	—	$48.0B	$3.1B	$1.2B
Q2 25	—	—	—	$50.8B	$3.2B	$1.3B
Q3 25	—	—	—	$50.4B	$3.2B	$1.3B
Q2 26	—	—	—	$60.7B	$3.3B	$1.7B

Revenue by Geography

Quarter	Non-US	United States
Q1 20	$1.0B	$36.3B
Q2 20	$1.1B	$38.7B
Q3 20	$1.1B	$38.1B
Q4 20	$1.0B	$35.7B
Q1 21	$1.1B	$38.0B
Q2 21	$1.2B	$40.4B
Q1 22	$1.1B	$42.8B
Q2 22	$1.1B	$44.4B
Q3 22	$1.1B	$43.7B
Q2 23	$1.1B	$50.3B
Q2 24	$1.2B	$56.2B
Q3 24	$1.2B	$53.7B
Q1 25	$408M	$51.9B
Q2 25	$428M	$54.9B
Q3 25	$399M	$54.5B
Q2 26	$435M	$65.2B

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$2.4B	$0	$2.4B
Q4 22	$4.7B	$0	$4.7B
Q1 23	$3.5B	$0	$3.5B
Q2 23	$3.7B	$0	$3.7B
Q3 23	$4.0B	$0	$4.0B
Q4 23	$4.1B	$0	$4.1B
Q1 24	$3.9B	$0	$3.9B
Q2 24	$4.6B	$0	$4.6B
Q3 24	$3.7B	$0	$3.7B
Q4 24	$5.1B	$0	$5.1B
Q1 25	$2.9B	$0	$2.9B
Q2 25	$3.8B	$0	$3.8B
Q3 25	$3.3B	$0	$3.3B
Q4 25	$3.9B	$0	$3.9B
Q1 26	$4.6B	$0	$4.6B
Q2 26	$2.8B	$0	$2.8B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 20	296M	-1.0%	-4.5%
Q2 20	294M	-0.7%	-3.9%
Q3 20	294M	0.0%	-2.0%
Q4 20	294M	0.0%	-1.7%
Q1 21	293M	-0.3%	-1.0%
Q2 21	295M	+0.7%	+0.3%
Q1 22	289M	-2.0%	-1.7%
Q2 22	281M	-2.8%	-4.4%
Q3 22	275M	-2.1%	-6.1%
Q2 23	261M	-5.1%	-11.5%
Q2 24	246M	-5.7%	-14.9%
Q3 24	245M	-0.4%	-12.8%
Q1 25	245M	0.0%	-10.9%
Q2 25	243M	-0.8%	-6.9%
Q3 25	241M	-0.8%	-2.0%
Q2 26	237M	-1.7%	-3.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 20	$1M	31K
Q2 20	$1M	31K
Q3 20	$1M	31K
Q4 20	$1M	30K
Q1 21	$1M	30K
Q2 21	$1M	30K
Q1 22	$929.6K	47K
Q2 22	$961.0K	47K
Q3 22	$947.9K	47K
Q2 23	$1M	47K
Q2 24	$1M	48K
Q3 24	$1M	48K
Q1 25	$1M	49K
Q2 25	$1M	49K
Q3 25	$1M	49K
Q2 26	$1M	58K

Revenue / Employee